Patent 12012459 was granted and assigned to Inhibrx on June, 2024 by the United States Patent and Trademark Office.
Provided herein are VHH-containing polypeptides that bind OX40. In some embodiments, VHH-containing polypeptides that bind and agonize OX40 are provided. Uses of the VHH-containing polypeptides are also provided.